| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Isocitrate dehydrogenase [NADP] cytoplasmic [R132C] |
|---|
| Ligand | BDBM279869 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | In Vitro Assays for IDH1m (R132H or R132C) Inhibitors |
|---|
| IC50 | >1000±n/a nM |
|---|
| Citation |  Konteatis, ZD; Popovici-Muller, J; Travins, J; Zahler, R; Cai, Z; Zhou, D Therapeutically active compounds and their methods of use US Patent US10946023 Publication Date 3/16/2021 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Isocitrate dehydrogenase [NADP] cytoplasmic [R132C] |
|---|
| Name: | Isocitrate dehydrogenase [NADP] cytoplasmic [R132C] |
|---|
| Synonyms: | IDH1 | IDH1 R132C | IDH1(R132C) | IDHC_HUMAN | Isocitrate dehydrogenase (IDH1)(R132C) | Isocitrate dehydrogenase 1 mutant (R132C) | Isocitrate dehydrogenase [NADP] cytoplasmic (IDH1) (R132C) | PICD |
|---|
| Type: | Enzyme Catalytic Domain |
|---|
| Mol. Mass.: | 46607.23 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | O75874[R132C] |
|---|
| Residue: | 414 |
|---|
| Sequence: | MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDA
AEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRL
VSGWVKPIIIGCHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAM
GMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFE
AQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDG
KTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALE
EVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKL
|
|
|
|---|
| BDBM279869 |
|---|
| n/a |
|---|
| Name | BDBM279869 |
|---|
| Synonyms: | US10028961, Compound 16 | US10028961, Compound 82 | US10172864, Compound 82 | US10946023, Compound 82 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C20H27N5O |
|---|
| Mol. Mass. | 353.4613 |
|---|
| SMILES | C[C@@H](Nc1nc(N[C@H](C)C2CC2)nc(n1)-c1cccc(CO)c1)C1CC1 |r| |
|---|
| Structure | 
|
|---|
Search and Browse
